Evidence map›Paper›PMID 24019420›Full record

Trial reportPediatrics2013

Vitamin D₃supplementation and childhood diarrhea: a randomized controlled trial.

Adam R Aluisio, Zabihullah Maroof, Daniel Chandramohan, Jane Bruce, M Zulf Mughal, Zulfiqar Bhutta, Gijs Walraven, Mohammad I Masher, Jeroen H J Ensink, Semira Manaseki-Holland

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 5 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 5 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Vitamin DBMC infectious diseases · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Vitamin D prophylaxis in infancy.BMC pediatrics · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Adam R AluisioMSc, SUNY Downstate Medical Center, Department of Emergency Medicine, 450 Clarkson Ave, Brooklyn, NY 11203. adam.aluisio@gmail.com.
Zabihullah Maroof
Daniel Chandramohan
Jane Bruce
M Zulf Mughal
Zulfiqar Bhutta
Gijs Walraven
Mohammad I Masher
Jeroen H J Ensink
Semira Manaseki-Holland
London School of Hygiene & Tropical Medicine · GBAga Khan Development Network · PKAga Khan University · PKKabul Medical University · AFRoyal Manchester Children's Hospital · GBUniversity of Birmingham · GBUniversity of London · GB

Funding

Wellcome TrustWellcome Trust 082476/Z/07/Z
6 · The paper itself

Abstract

objectiveTo investigate the effect of vitamin D3 supplementation on the incidence and risk for first and recurrent diarrheal illnesses among children in Kabul, Afghanistan.

methodsThis double-blind placebo-controlled trial randomized 3046 high-risk 1- to 11-month-old infants to receive 6 quarterly doses of oral vitamin D3 (cholecalciferol 100000 IU) or placebo in inner city Kabul. Data on diarrheal episodes (≥ 3 loose/liquid stools in 24 hours) was gathered through active and passive surveillance over 18 months of follow-up. Time to first diarrheal illness was analyzed by using Kaplan-Meier plots. Incidence rates and hazard ratios (HRs) were calculated by using recurrent event Poisson regression models.

resultsNo significant difference existed in survival time to first diarrheal illness (log rank P = .55). The incidences of diarrheal episodes were 3.43 (95% confidence interval [CI], 3.28-3.59) and 3.59 per child-year (95% CI, 3.44-3.76) in the placebo and intervention arms, respectively. Vitamin D3 supplementation was found to have no effect on the risk for recurrent diarrheal disease in either intention-to-treat (HR, 1.05; 95% CI, 0.98-1.17; P = .15) or per protocol (HR, 1.05; 95% CI, 0.98-1.12; P = .14) analyses. The lack of preventive benefit remained when the randomized population was stratified by age groups, nutritional status, and seasons.

conclusionsQuarterly supplementation with vitamin D3 conferred no reduction on time to first illness or on the risk for recurrent diarrheal disease in this study. Similar supplementation to comparable populations is not recommended. Additional research in alternative settings may be helpful in elucidating the role of vitamin D3 supplementation for prevention of diarrheal diseases.

Indexed as

Dietary SupplementsAfghanistanChild, PreschoolCholecalciferolDiarrheaDiarrhea, InfantileDouble-Blind MethodFemaleFollow-Up StudiesHumansInfantMaleRiskCholecalciferolAfghanistanchildrendiarrhea preventionvitamin D supplementation

Identifiers

PMID24019420
PMCPMC3866796
OpenAlexW2129216310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.